Breaking News, Promotions & Moves

Cytovance Appoints CEO

Bin Zhang has been with Cytovance as a member of the Board of Directors since 2018.

By: Contract Pharma

Contract Pharma Staff

Cytovance Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and microbial biologics, has appointed Bin Zhang as chief executive officer.   Zhang served two months as Interim CEO before this formal appointment by the board to CEO. He will report to Mr. Li Li, founder and chairman of the Board for Shenzhen Hepalink Pharmaceutical Group Co. Ltd. and member of the Board for Cytovance.   Zhang has been with Cytovance as a member of the Board of Dir...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters